Northeast GI Research Division — Concord, North Carolina

Northeast GI Research Division is a clinical research site located in Concord, North Carolina, United States 28027.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Northeast GI Research Division has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Non-alcoholic Steatohepatitis, Nonalcoholic Steatohepatitis, Non-alcoholic Steatohepatitis (NASH).

Sponsors: Novo Nordisk A/S, Tobira Therapeutics, Inc., Boehringer Ingelheim.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northeast GI Research Division?

Northeast GI Research Division has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northeast GI Research Division conducted?

Northeast GI Research Division has 8 clinical trials on record, with 1 currently active. Their work covers Non-alcoholic Steatohepatitis, Nonalcoholic Steatohepatitis, Non-alcoholic Steatohepatitis (NASH).

Is Northeast GI Research Division accredited by Crixeo Health?

Yes — Northeast GI Research Division holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Northeast GI Research Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.